Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hedvig Takács
Observed names:
H Takacs,
Takács, Hedvig
Institution:
University of Szeged
Observed institutions:
Semmelweis University,
Tampere University,
University of Szeged,
Liverpool Heart and Chest Hospital,
AlbaNova,
University of Tampere,
University of Pecs,
KTH Royal Institute of Technology
show all 8
ORCID:
0000-0002-5424-3898
Observed ORCID:
0000-0002-5424-3898
OpenAlex ID:
A5000751016
The Genetic Architecture of Hypertrophic Cardiomyopathy in Hungary: Analysis of 242 Patients with a Panel of 98 Genes
2022
·
Róbert Sepp
, Lidia Hategan
, et al.
·
Diagnostics
·
23
Variant Transthyretin Amyloidosis (ATTRv) in Hungary: First Data on Epidemiology and Clinical Features
2021
·
Zoltán Pozsonyi
, Gergely Peskó
, et al.
·
Genes
·
15
PDF
New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts
2016
·
Péter Kui
, Szabolcs Orosz
, et al.
·
Journal of Pharmacological and Toxicological Methods
·
11
Screening for Myocardial Injury after Mild SARS-CoV-2 Infection with Advanced Transthoracic Echocardiography Modalities
2022
·
Gergely Rácz
, Hedvig Takács
, et al.
·
Diagnostics
·
10
PDF
Long-Term Endurance Exercise Training Alters Repolarization in a New Rabbit Athlete’s Heart Model
2022
·
Péter Kui
, Alexandra Polyák
, et al.
·
Frontiers in Physiology
·
10
Novel Electrocardiographic Criteria May Render Possible the More Accurate Recognition of Cardiac Amyloidosis
2024
·
András Vereckei
, Gábor Katona
, et al.
·
ESC Heart Failure
·
9
PDF
Mavacamten effectively reduces > 100 mmHg left ventricular outflow tract gradients as early as one week of treatment in obstructive hypertrophic cardiomyopathy
2025
·
Viktória Nagy
, Gergely Rácz
, et al.
·
International Journal of Cardiology
·
4
PDF
Hyperventilation assists proarrhythmia development during delayed repolarization in clofilium-treated, anaesthetized, mechanically ventilated rabbits.
2016
·
H Papp
, A Sarusi
, et al.
·
PubMed
·
2
PDF
Ventricular cycle length irregularity affects the correlation between ventricular rate and coronary flow in isolated, Langendorff perfused guinea pig hearts
2015
·
Hedvig Takács
, Péter Kui
, et al.
·
Journal of Pharmacological and Toxicological Methods
·
2
Characterisation of interrelations among myocardial work parameters in patients with hypertrophic cardiomyopathy: differences between non-obstructive and obstructive disease
2026
·
Viktória Nagy
, Gergely Rácz
, et al.
·
Frontiers in Cardiovascular Medicine
·
1
PDF
Az Európai Kardiológus Társaság 2021-es szívelégtelenség-ajánlásának 2023-as, fókuszált update-je
2024
·
Viktória Nagy
, Hedvig Takács
, et al.
·
Cardiologia Hungarica
·
1
Fabry-betegséget okoz-e a GLA gén p.Ala143Thr variánsa?
2023
·
Viktória Nagy
, Gergely Rácz
, et al.
·
Cardiologia Hungarica
·
1
PDF
A szívamyloidosis diagnosztikájának és terápiájának aktualitásai : Az ESC Myocardial and Pericardial Diseases Munkacsoportjának 2021-es position statementje alapján
2022
·
Hedvig Takács
, Viktória Nagy
, et al.
·
Cardiologia Hungarica
·
1
PDF
Genetic diagnosis in hypertrophic cardiomyopathy: two steps forward, one step back
2021
·
Lidia Hategan
, Beáta Csányi
, et al.
·
Cardiologia Hungarica
·
1
PDF
Balkamra-hipertrófia mértékét jellemző paraméterek összefüggése MRI-vel meghatározott bal kamrai izomtömeggel hipertrófiás cardiomyopathiában
2020
·
Viktória Nagy
, Attila Pálinkás
, et al.
·
Cardiologia Hungarica
·
1
PDF
An improved way to set up a more accurate presumptive diagnosis of cardiac amyloidosis
2026
·
A Vereckei
, H Takacs
, et al.
·
European Heart Journal
Atrial fibrillation during mavacamten treatment in obstructive hypertrophic cardiomyopathy in the real-world: data from the multicenter MARVEL.HU registry on 133 patients
2026
·
V Nagy
, N Schvartz
, et al.
·
European Heart Journal
PDF
How to query administrative databases for heart failure epidemiological investigations? Rationale, design, and case definition criteria for the nation-wide HF-EPI-HUN Study
2026
·
Róbert Sepp
, Bálint Mazzag
, et al.
·
European Journal of Heart Failure
Effectiveness and safety of mavacamten in obstructive hypertrophic cardiomyopathy in the real world: one-year data from the multicentre MARVEL.HU study
2026
·
R Sepp
, B P Polestyuk
, et al.
·
European Journal of Heart Failure
Development of case definition criteria for querying insurance databases in heart failure epidemiological investigations: rationale and design of the HF-EPI-HUN study
2026
·
R Sepp
, B Mazzag
, et al.
·
European Journal of Heart Failure
Right-sided cardiac echocardiographic parameters show no major change during 3-months mavacamten treatment in obstructive hypertrophic cardiomyopathy
2026
·
N Schvartz
, V Nagy
, et al.
·
European Heart Journal - Cardiovascular Imaging
Echocardiographic parameters of left ventricular diastolic dysfunction, left atrial volumes and left atrial function improves in obstructive hypertrophic cardiomyopathy during mavacamten treatment
2026
·
H Takacs
, V Nagy
, et al.
·
European Heart Journal - Cardiovascular Imaging
Pseudonormalization of global myocardial work index and global constructive work, but not global wasted work, in patients with obstructive hypertrophic cardiomyopathy
2026
·
A Kormanyos
, G Racz
, et al.
·
European Heart Journal - Cardiovascular Imaging
Sarcomere gene mutations leading to lower myocardial work values in hypertrophic cardiomyopathy
2025
·
H Takacs
, G Racz
, et al.
·
European Heart Journal - Cardiovascular Imaging
PDF
The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment
2025
·
V Nagy
, G Racz
, et al.
·
European Heart Journal - Cardiovascular Imaging
PDF
Show more works
View as search
Works count:
39
Citation count:
92
H-index:
6
I10-index:
5
Year
Topic
Type
